Member Login
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • GSK (LSE: GSK) Latest News

    Senior Adult Black Female Tourist Admiring London
    Investing Articles

    See what £10k invested in ailing GSK shares is worth today…

    | Harvey Jones

    No investor will be happy with their GSK shares as the FTSE 100 pharmaceutical giant has had a dismal decade.…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    What are the most common FTSE 100 shares top UK investors put into a Stocks and Shares ISA?

    | Mark Hartley

    Mark Hartley reveals the three most popular FTSE 100 shares found in Stocks and Shares ISAs — and why so…

    Read more »

    US Tariffs street sign
    Investing Articles

    Gold soaring, oil at risk, bonds irrational: what’s going on with the US stock market?

    | Mark Hartley

    With the US stock market acting irrationally, this Fool UK writer explains why he’s focusing on defensive shares to avoid…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    Is this FTSE 100 pharma gem now a brilliant bargain?

    | Simon Watkins

    This FTSE 100 pharmaceutical giant has been hit by fears of US tariffs and litigation over a key product, but…

    Read more »

    Man riding the bus alone
    Investing Articles

    Is the GSK share price finally getting its act together?

    | Harvey Jones

    The GSK share price has had a horrible millennium. Harvey Jones can't believe how bad it's been. But are we…

    Read more »

    UK coloured flags waving above large crowd on a stadium sport match.
    Investing Articles

    2 world-class UK dividend stocks available at bargain-basement prices. Time to consider buying?

    | Harvey Jones

    Harvey Jones picks out two FTSE 100 dividend stocks with brilliant pasts. Are they set to reward investors in the…

    Read more »

    Businessman hand stacking money coins with virtual percentage icons
    Investing Articles

    Why this FTSE 100 pharma stock is one for investors to consider right now

    | Ken Hall

    Ken Hall takes a closer look at GSK after the FTSE 100 pharmaceutical giant's positive first quarter earnings update.

    Read more »

    Investing Articles

    Should I buy the most popular FTSE 100 stock on AJ Bell?

    | Ben McPoland

    Our writer can see the appeal of this recently popular dividend stock from the FTSE 100 index. But will he…

    Read more »

    Young Asian man drinking coffee at home and looking at his phone
    Investing Articles

    Does the GSK or AstraZeneca share price currently offer the best value?

    | Dr. James Fox

    The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma…

    Read more »

    Investing Articles

    Down 20% over the year, is GSK’s share price a stunning bargain after its Q1 results?

    | Simon Watkins

    GSK’s share price has fallen significantly in the past 12 months, but this could mean it looks a major bargain…

    Read more »

    Thoughtful man using his phone while riding on a train and looking through the window
    Investing Articles

    What’s going on with the GSK share price now?

    | Dr. James Fox

    This pharma giant was expected to deliver for investors after its split with Haleon, but the GSK share price has…

    Read more »

    UK financial background: share prices and stock graph overlaid on an image of the Union Jack
    Investing Articles

    Up 7.5% in a week! Is the GSK share price about to do an AstraZeneca?

    | Harvey Jones

    Harvey Jones says the GSK share price has dramatically underperformed FTSE 100 rival AstraZeneca, which has had a stellar run.…

    Read more »